Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)
暂无分享,去创建一个
Ossama K. Abou Hassan | A. Lincoff | S. Nissen | T. Wang | C. Sheng | A. Duggal | S. Dugar | D. Sahoo | V. Menon | D. Brennan | D. Culver | P. Cremer | P. Rajendram | Robier Aguillon Prada | O. A. Abou Hassan | A. Lincoff | Prabalini Rajendram | Paul C. Cremer | Steven E. Nissen | Calvin C Sheng | Tom Kai Ming Wang | Daniel A. Culver